Evaluating the Diagnostic Utility of PRAME and CD34 Dual Staining in Fibrosarcomatous Dermatofibrosarcoma Protuberans
Indian Journal of Dermatology · 30.10.2026
DOI: 10.4103/ijd.ijd_602_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Dermatology, online erschienen am 30.10.2026. Verfasst von Mokhtar H. Abdelhammed und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Preferentially expressed Antigen in Melanoma (PRAME) is a melanoma-associated antigen that has shown its utility in distinguishing melanoma from benign melanocytic nevi. However, it is reported to express in various other malignancies. Fibrosarcomatous dermatofibrosarcoma protuberans (FS-DFSP) is a high-grade variant of conventional dermatofibrosarcoma protuberans (C-DFSP), characterized by increased cellularity, mitotic activity, and nuclear atypia, with a higher risk of metastasis. Distinguishing FS-DFSP from C-DFSP can be challenging, particularly in cases with ambiguous morphological features. Immunohistochemically, most cases of C-DFSP show diffuse and strong cytoplasmic expression of CD34. Nonetheless, there may be diminished or absent CD34 expressions in FS-DFSP. We present a case of a 49-year-old man with FS-DFSP confirmed by COL1A1:PDGFB fusion, demonstrating a loss of CD34 and positive PRAME expression. This case signifies the potential utility of the CD34-PRAME dual-marker approach in diagnosing FS-DFSP, particularly in morphologically challenging cases. PRAME-positive cases of FS-DFSP can also be considered as a potential therapeutic target with PRAME-specific immunotherapy.
Zitieren
APA
Abdelhammed, M. H., Ittmann, M. M., & Ramani, N. S. (2026). Evaluating the Diagnostic Utility of PRAME and CD34 Dual Staining in Fibrosarcomatous Dermatofibrosarcoma Protuberans. Indian Journal of Dermatology. https://doi.org/10.4103/ijd.ijd_602_25
Vancouver
Abdelhammed MH, Ittmann MM, Ramani NS. Evaluating the Diagnostic Utility of PRAME and CD34 Dual Staining in Fibrosarcomatous Dermatofibrosarcoma Protuberans. Indian Journal of Dermatology. 2026. doi:10.4103/ijd.ijd_602_25
BibTeX
@article{Abdelhammed2026,
author = {Abdelhammed, Mokhtar H. and Ittmann, Michael M. and Ramani, Nisha S.},
title = {Evaluating the Diagnostic Utility of PRAME and CD34 Dual Staining in Fibrosarcomatous Dermatofibrosarcoma Protuberans},
journal = {Indian Journal of Dermatology},
year = {2026},
doi = {10.4103/ijd.ijd_602_25}
}
EUVIMED